Results 31 to 40 of about 6,262 (184)

Bioprosthetic vs. Mechanical Mitral Valve Replacement for Rheumatic Heart Disease in Patients Aged 50–70 Years

Frontiers in Cardiovascular Medicine, 2022
BackgroundRheumatic heart disease (RHD) is a critical problem in developing countries and is the cause of most of the cardiovascular adverse events in young people.
Jun Yu, Wei Wang
doaj   +1 more source

Degeneration of Bioprosthetic Heart Valves: Update 2020

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2020
The implantation of bioprosthetic heart valves (BHVs) is increasingly becoming the treatment of choice in patients requiring heart valve replacement surgery.
Alexander E. Kostyunin, Arseniy E. Yuzhalin, Maria A. Rezvova, Evgeniy A. Ovcharenko, Tatiana V. Glushkova, Anton G. Kutikhin   +5 more
doaj   +1 more source

Bicuspid mitral bioprosthesis. [PDF]

Thorax, 1981
A bicuspid mitral bioprosthesis was prepared by mounting glutaraldehyde-processed porcine pericardium onto commercially available Brownlee-Yates stents. The bioprostheses were inserted into 17 dogs. Haemodynamic performance and long-term function of the valve was assessed.
E, Bodnar, N L, Bowden, P J, Drury, E G, Olsen, I, Durmaz, D N, Ross   +5 more
openaire   +2 more sources

Real-world early- to midterm outcomes of aortic valve replacement using novel tissue technology bioprosthesis at a high-volume centerCentral MessagePerspective

JTCVS Open
Objective: The INSPIRIS-RESILIA aortic valve (Edwards Lifesciences) uses a novel tissue-fixation technology to enhance the bioprosthesis's longevity. We sought to report midterm INSPIRIS-RESILIA aortic bioprosthesis performance in a large contemporary ...
Emily Vianna, MD, Patrick R. Vargo, MD, L. Leonardo Rodriguez, MD, Salvatore Poddi, MD, Kelsey Curran, MPH, Jeevanantham Rajeswaran, PhD, Shinya Unai, MD, Eric E. Roselli, MD, Lars G. Svensson, MD, PhD, Haytham Elgharably, MD, PhD   +9 more
doaj   +1 more source

Transcatheter Valve-in-Valve Procedures for Bioprosthetic Valve Dysfunction in Patients With Rheumatic vs. Non-Rheumatic Valvular Heart Disease

Frontiers in Cardiovascular Medicine, 2021
Background: Bioprosthetic heart valve has limited durability and lower long-term performance especially in rheumatic heart disease (RHD) patients that are often subject to multiple redo operations.
Mariana Pezzute Lopes, Vitor Emer Egypto Rosa, José Honório Palma, Marcelo Luiz Campos Vieira, Joao Ricardo Cordeiro Fernandes, Antonio de Santis, Guilherme Sobreira Spina, Rafael de Jesus Fonseca, Mauricio F. de Sá Marchi, Alexandre Abizaid, Fábio Sândoli de Brito, Flavio Tarasoutchi, Roney Orismar Sampaio, Henrique Barbosa Ribeiro   +13 more
doaj   +1 more source

Validation of an Automated Artificial Intelligence‐Driven Planner for Transcatheter Aortic Valve Replacement

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Preprocedural planning with multislice computed tomography (MSCT) is an essential prerequisite for successful transcatheter aortic valve replacement (TAVR). However, preprocedural planning is time‐consuming and may contain clinically meaningful interobserver variability.
Mark M. P. van den Dorpel, Lucas Uchoa de Assis, Jenna van Niekerk, Sophie Deckx, Matthew Sherman, Janelle Schrot, Anna Kozak, Isabella Kardys, Alexander Hirsch, Joost Daemen, Rutger Jan Nuis, Nicolas M. Van Mieghem   +11 more
wiley   +1 more source

Comparison of Surgical Treatment Outcomes in Patients with Symptomatic Severe Aortic Valve Stenosis Using the Perceval Sutureless Bioprosthesis Versus a Conventional Biological Valve

Journal of Cardiovascular Development and Disease
Objectives: This single-center retrospective comparative cohort study aimed to compare the outcomes of aortic valve replacement using a Perceval sutureless bioprosthesis versus a conventional stented bioprosthesis in patients with symptomatic severe ...
Dejan M. Lazović, Milica Karadžić, Filip Vučićević, Gorica Marić, Miloš Grujić, Ivana Đurošev, Mladen J. Kočica, Svetozar Putnik, Dragan Cvetković   +8 more
doaj   +1 more source

Prevention by the CXCR2 antagonist SCH527123 of the calcification of porcine heart valve cusps implanted subcutaneously in rats

Frontiers in Cardiovascular Medicine, 2023
IntroductionCalcification is a main cause of bioprosthetic heart valves failure. It may be promoted by the inflammation developed in the glutaraldehyde (GA)-fixed cusps of the bioprosthesis. We tested the hypothesis that antagonizing the C-X-C chemokines
Yuthiline Chabry, Yuthiline Chabry, Yuthiline Chabry, Kawthar Dhayni, Saïd Kamel, Saïd Kamel, Thierry Caus, Thierry Caus, Youssef Bennis, Youssef Bennis   +9 more
doaj   +1 more source

Frailty and Five‐Year Mortality After TAVR in Patients Aged 75 Years and Older

Journal of the American Geriatrics Society, EarlyView.
In patients aged 75 years and older undergoing transcatheter aortic valve replacement, frailty assessed by the Clinical Frailty Scale was the most robust geriatric factor independently associated with five‐year mortality. This study highlights the specific prognostic value of frailty beyond short‐term outcomes.
Jérémie Huet, Mélissa Sabin, Thierry Le Tourneau, Thibaut Manigold, Anne‐Sophie Boureau   +4 more
wiley   +1 more source

Comparison of a novel mechanical valve versus stented bioprosthetic valves for isolated mitral valve replacement in patients older than 65 yearsCentral MessagePerspective

JTCVS Open
Objective: To compare early and long-term clinical outcomes of bioprosthetic versus mechanical (On-X) mitral valve replacement (MVR) in patients aged 65 years and older.
Antonio Piperata, MD, PhD, Carlo Mariani, MD, PhD, Giacomo Murana, MD, PhD, Elio Fabbri, PhD, Paola Rucci, PhD, Maria Francesca Scuppa, MD, Filippo Londi, MD, Edoardo Bianco, MD, Benedetta Guerrini, MD, Ivan Tammaro, MD, Ludovica Fabiani, MD, Margherita Careddu, MD, Marta Bellomare, MD, Silvia Snaidero, MD, Riccardo Nania, MD, Sabrina Castagnini, MD, Marta Di Carlo, MD, Valentina Orioli, MD, Gianluca Folesani, MD, Davide Pacini, MD, PhD   +19 more
doaj   +1 more source